SLC22A16
Solute carrier family 22 member 16
Also known as: CT2, FLIPT2, OAT6, OKB1, S22AG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86VW1
- Gene
- SLC22A16
- Ensembl
- ENSG00000004809
- Chromosome
- 6
- Canonical length
- 577 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a member of the organic zwitterion transporter protein family which transports carnitine. The encoded protein has also been shown to transport anticancer drugs like bleomycin (PMID: 20037140) successful treatment has been correlated with the level of activity of this transporter in tumor cells. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
577 residues, UniProt reviewed canonical sequence.
>Q86VW1|SLC22A16
1 MGSRHFEGIY DHVGHFGRFQ RVLYFICAFQ NISCGIHYLA SVFMGVTPHH VCRPPGNVSQ
61 VVFHNHSNWS LEDTGALLSS GQKDYVTVQL QNGEIWELSR CSRNKRENTS SLGYEYTGSK
121 KEFPCVDGYI YDQNTWKSTA VTQWNLVCDR KWLAMLIQPL FMFGVLLGSV TFGYFSDRLG
181 RRVVLWATSS SMFLFGIAAA FAVDYYTFMA ARFFLAMVAS GYLVVGFVYV MEFIGMKSRT
241 WASVHLHSFF AVGTLLVALT GYLVRTWWLY QMILSTVTVP FILCCWVLPE TPFWLLSEGR
301 YEEAQKIVDI MAKWNRASSC KLSELLSLDL QGPVSNSPTE VQKHNLSYLF YNWSITKRTL
361 TVWLIWFTGS LGFYSFSLNS VNLGGNEYLN LFLLGVVEIP AYTFVCIAMD KVGRRTVLAY
421 SLFCSALACG VVMVIPQKHY ILGVVTAMVG KFAIGAAFGL IYLYTAELYP TIVRSLAVGS
481 GSMVCRLASI LAPFSVDLSS IWIFIPQLFV GTMALLSGVL TLKLPETLGK RLATTWEEAA
541 KLESENESKS SKLLLTTNNS GLEKTEAITP RDSGLGELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC22A16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- testis: 20 nTPM
- bone marrow: 19 nTPM
- parathyroid gland: 3.5 nTPM
- smooth muscle: 1.6 nTPM
- thymus: 1.1 nTPM
- endometrium: 0.7 nTPM
Single-cell type
- erythrocyte progenitors: 120 nCPM
- late primary spermatocytes: 113 nCPM
- hematopoietic stem cells: 50 nCPM
- late spermatids: 46 nCPM
- neutrophil progenitors: 45 nCPM
- early spermatids: 36 nCPM
Immune cell
- classical monocyte: 7 nTPM
- basophil: 5.8 nTPM
- myeloid DC: 4 nTPM
- intermediate monocyte: 1.5 nTPM
- total PBMC: 1.5 nTPM
- eosinophil: 1.3 nTPM
Brain region
- white matter: 0.7 nTPM
- medulla oblongata: 0.5 nTPM
- basal ganglia: 0.3 nTPM
- cerebral cortex: 0.3 nTPM
- midbrain: 0.3 nTPM
- pons: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.64
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acid secretion
- carnitine transmembrane transport
- carnitine transport
- cell differentiation
- flagellated sperm motility
- monoatomic ion transport
- organic cation transport
- single fertilization
- spermatogenesis
- spermidine transmembrane transport
Molecular functions
- amine transmembrane transporter activity
- carnitine transmembrane transporter activity
- organic cation transmembrane transporter activity
- spermidine transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC22A16 as an antibody target. Whether an autoantibody or antibody against SLC22A16 could matter depends on whether native SLC22A16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC22A16 is annotated at the cell surface, where native SLC22A16 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC22A16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...